バイオバンク
研究業績
  1. Hattori Y, Kakino Y, Hattori Y, Iwashita M, Uchiyama H, Noda K, Yoshimoto T, Iida H, Ihara M. Long-Term Resveratrol Intake for Cognitive and Cerebral Blood Flow Impairment in Carotid Artery Stenosis/Occlusion. Journal of Stroke. 26, 64-74, 2024.
  2. Kiko T, Asano R, Ishibashi T, Endo H, Nishi N, Hayashi H, Ueda J, Aoki T, Tsuji A, Nakaoka Y, Ogo T. Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. 13, e035009, 2024.
  3. Morooka N, Gui N, Ando K, Sako K, Fukumoto M, Hasegawa U, Hußmann M, Schulte-Merker S, Mochizuki N, Nakajima H. Angpt1 binding to Tie1 regulates the signaling required for lymphatic vessel development in zebrafish. Development. 151, dev202269, 2024.
  4. Noda K, Hattori Y, Murata H, Kokubo Y, Higashiyama A, Ihara M. Equol Nonproducing Status as an Independent Risk Factor for Acute Cardioembolic Stroke and Poor Functional Outcome. Nutrients. 16, 3377, 2024.
  5. Simats A, Zhang SJ, Messerer D, Chong FY, Beskardes S, Chivukula AS, Cao JY, Besson-Girard S, Montellano FA, Morbach C, Carofiglio O, Ricci A, Roth S, Llovera G, Singh R, Chen YM, Filser S, Plesnila N, Braun C, Spitzer H, Gokce O, Dichgans M, Heuschmann PU, Hatakeyama K, Beltrán E, Clauss S, Bonev B, Schulz C, Liesz A. Innate immune memory after brain injury drives inflammatory cardiac dysfunction. Cell. 187, 4637-4655.e26, 2024.
  6. Hattori Y, Kakino Y, Kiyoshige E, Ogata S, Nishimura K, Iida H, Ihara M. Blood Midregional Proadrenomedullin as a Hemodynamic Severity Marker in Asymptomatic Carotid Artery Stenosis/Occlusion. Stroke. 55, e182-e184, 2024.
  7. Maruyama K, Kokame K. Development of an assay using a modified coagulation factor V to measure protein S activity. Journal of Thrombosis and Haemostasis. 22, 3510-3520, 2024.
  8. Shimamoto K, Dagradi F, Ohno S, Spazzolini C, Crotti L, Giovenzana FLF, Musu G, Pedrazzini M, Kusano K, Takegami M, Nishimura K, Horie M, Aiba T, Schwartz PJ. Clinical Features, Long-Term Prognosis, and Clinical Management of Genotype-Negative Long QT Syndrome Patients. JACC: Clinical Electrophysiology. 10, 2584-2596, 2024.
  9. Shimamoto K, Sumitomo N, Nabeshima T, Ohno S, Shimizu W, Kusano K, Aiba T. Novel Compound Heterozygous Variants in Trans-2,3-Enoyl-Coenzyme A Reductase-Like Gene Associated With Catecholaminergic Polymorphic Ventricular Tachycardia. JACC: Case Reports. 29, 102364, 2024.